{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T05:12:45Z","timestamp":1772773965756,"version":"3.50.1"},"reference-count":24,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":4684,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1995,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>OBJECTIVE<\/jats:bold> Hyperthyroidism is a risk factor for osteoporosis, but the relative contributions of the episode of hyperthroidism and thyroxine replacement for subsequent hypothroidism remain uncertain. In this study we have measured bone mineral density (BMD) in post\u2010menopausal women with a previous history of hyperthyroidism, comparing those requiring thyroxine therapy with those remaining euthyroid and with an historical local control population.<\/jats:p><jats:p><jats:bold>DESIGN<\/jats:bold> Cross\u2010sectional study.<\/jats:p><jats:p><jats:bold>PATIENTS<\/jats:bold> One hundred and SIX post\u2010menopausal women with a previous history of hyperthyroldism. These were divided Into four groups: treated with radiolodine, remaining euthyroid (group RU, n = 15); treated with radiolodine, receiving thyroxine for at least 5 years (group RT, n = 46); treated with surgery, remaining euthyrold (group SU, n = 21); treated with surgery, receiving thyroxine for at least 5 years (group ST, n = 24). There were 102 control subjects.<\/jats:p><jats:p><jats:bold>MEASUREMENT<\/jats:bold> Forearm bone mineral density at distal and ultradistal sites as measured by single\u2010photon absorptlometry.<\/jats:p><jats:p><jats:bold>RESULTS<\/jats:bold> Results were expressed as \u20182\u2010scores\u2019 i.e. number of standard deviatlons from the mean of a 5\u2010year age\u2010band from the local control population. Mean Z\u2010scores at distal and ultradistal sites were as follows: \u22120.61 and \u22120.81 in group RU; \u22120.58 and \u22120.56 In group RT; \u22120.27 and \u22120.30 in group SU; \u22120.81 and \u22120.57 In group ST. Patients in groups RU, RT and ST but not SU had significantly lower BMD than controls.<\/jats:p><jats:p><jats:bold>CONCLUSION<\/jats:bold> Post\u2010menopausal women with previous hyperthyroidism treated with radioladine have reduced BMD, whether or not receiving thyroxine. They should be targeted for densitometry and protective therapy with oestrogen should be considered. Those treated with surgery appear to be at less risk; this may be because most are diagnosed and treated whilst premenopausal. Thyroxine may have a deleterious effect in this group; longitudinal studies would provide further clarification.<\/jats:p>","DOI":"10.1111\/j.1365-2265.1995.tb02041.x","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T10:25:34Z","timestamp":1205749534000},"page":"339-345","source":"Crossref","is-referenced-by-count":31,"title":["Is previous hyperthyroidism still a risk factor for osteoporosis in post\u2010menopausal women?"],"prefix":"10.1111","volume":"43","author":[{"given":"David J.","family":"Grant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion E. T.","family":"McMurdo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia A.","family":"Mole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin R.","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90577-K"},{"key":"e_1_2_1_3_1","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1210\/jcem.78.4.8157703","article-title":"Editorial: detrimental skeletal effects of thyrotropin suppressive doses of thyroxine: fact or fantasy","volume":"78","author":"Baran D.T.","year":"1994","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"e_1_2_1_4_1","first-page":"121","article-title":"Hyperthyroidism increases the risk of hip fractures: a prospective study","volume":"7","author":"Bauer D.C.","year":"1992","journal-title":"Journal of Bone and Mineral Research"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92555-8"},{"key":"e_1_2_1_6_1","first-page":"81","article-title":"Methods for measuring bone mineral density","volume":"7","author":"Eastell R.","year":"1990","journal-title":"Bone"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1300350"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1993.tb02403.x"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)92423-D"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1994.tb02572.x"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1993.tb02404.x"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90066-7"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-72-6-1189"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1992.tb01480.x"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.78.4.818"},{"key":"e_1_2_1_16_1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0030-5898(20)30490-9","article-title":"Bony manifestations of thyrotoxicosis","volume":"3","author":"Meunier P.J.","year":"1972","journal-title":"Orthopedic Clinics of North America"},{"key":"e_1_2_1_17_1","first-page":"515","article-title":"Bone changes in hyperthyroidism. Interrelationship between bone morphometry, thyroid function and calcium\u2010phosphorus metabolism","volume":"85","author":"Mosekilde L.","year":"1977","journal-title":"Acta Endocrinologica"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.307.6912.1111"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1530\/acta.0.1260238"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1990.tb00477.x"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.75.6.1531"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.77.3.664"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90219-1"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510400031027"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1993.3.17"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.1995.tb02041.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.1995.tb02041.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T01:36:04Z","timestamp":1698370564000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.1995.tb02041.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,9]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,9]]}},"alternative-id":["10.1111\/j.1365-2265.1995.tb02041.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.1995.tb02041.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,9]]}}}